Ignite Creation Date:
2024-05-06 @ 10:53 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03379428
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-12
First Post:
2017-12-12
Brief Title:
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
Sponsor:
US Oncology Research
Organization:
US Oncology Research
Organization Data
Organization:
US Oncology Research
Class:
INDUSTRY
Study ID:
14059
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
US Oncology Research
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pharmacyclics LLC | INDUSTRY |
| AbbVie | INDUSTRY |